Latest News

Benefits of the Mediterranean Diet and Physical Activity in HS

January 2, 2024

Can Diet and Physical Activity Improve Your HS?
Read more


Barriers to Accessing Care for HS

September 7, 2023

Patient interviews highlight challenges in accessing HS care
Read more


Genetic Variants Associated with Hidradenitis Suppurativa

August 27, 2023

Two genes identified as likely associates with HS
Read more


Assessing the Impact of HS on Work Productivity

August 22, 2023

Study demonstrates decrease in work productivity due to HS
Read more


What is Pain Really Like for People with HS

June 8, 2023

Initial HS lesions present with itch, but can progress to pain.
Read more


Average Time Patients Stay on Biologic Treatment

June 8, 2023

Study Shows Treatment of HS is Challenging
Read more


Secukinumab and HS

May 3, 2023

Large Study Shows Improvement in HS with Secukinumab
Read more


Bimekizumab and HS

May 3, 2023

Safe and Effective Results Shown with Bimekizumab in Phase II Studies
Read more


Birth Control and HS

April 11, 2023

Small study shows birth control pills may be useful in the treatment of HS
Read more


Benefits of Finasteride in Women with HS

March 9, 2023

Can finasteride help control hidradenitis suppurativa in women?
Read more


Biologic Therapy Not Associated with COVID-19 Severity

February 1, 2023

Biologic Therapy Not Linked to COVID-19 Severity in People With HS
Read more


HS Foundation’s HS CAPE (Community Awareness and Patient Empowerment) Program Request for Proposals

January 9, 2023

The goal of the CAPE grant is to stimulate the development of programs that increase disease awareness, provide support to patients and caregivers, improve patient care or benefit patients with HS in other ways. Typical awards will be for up to $2,000 but proposals for up to $5,000 will be considered (direct costs only, regardless of the amount of the award). Award amount is contingent upon the availability of funds and the receipt of sufficiently meritorious applications.
Read more


A new treatment option for tunnels in HS

December 1, 2022

An Open-Label, Prospective, Pilot Study of Hypertonic Saline for Hidradenitis Suppurativa.
Read more


Interview with 2017 HSF Danby Grant Recipient Amanda Nelson, PhD

December 1, 2022

Learn about 2017 Danby Grant Recipient Amanda Nelson, PhD and her winning project which investigated whether skin stem cells were misplaced and abnormally active in HS lesions.
Read more


Interview with 2021 HSF Danby Grant Recipient Dr. Carmelo Carmona-Rivera, PhD

December 1, 2022

Learn about 2021 Danby Grant Recipient Dr. Carmelo Carmona-Rivera, PhD and his winning project which aimed to find disease-causing interactions between cells or between cells and NETs.
Read more


Adalimumab (Humira) in combination with surgery is safe and effective to treat hidradenitis suppurativa.

December 1, 2022

This study explored whether it was safe for patients to undergo skin surgery while on adalimumab.
Read more


Interview with 2018 HSF Danby Grant Recipient Angel Byrd, MD PhD

October 4, 2022

Learn about Danby Grant Recipient Angel Byrd, MD PhD and her winning project which aimed to establish a biorepository of HS tissue samples to better understand the disease.
Read more


Interview with 2020 HSF Danby Grant Recipient Dr. Lauren Orenstein

October 4, 2022

Learn about Dr. Lauren Orenstein's Danby Award-winning project which studied patterns of health care utilization and opioid prescription use among patients with hidradenitis suppurativa.
Read more


2019 HSF Danby Grant Awardee Dr. Abrar Qureshi Interview

August 9, 2022

HSF Danby Grant Funding Helps Develop a Useful Screening Tool for HS
Read more


View the latest research summary from the HS Foundation

August 4, 2022

A number of medical conditions are associated with HS - what are they?
Read more


Factors that affect delayed HS diagnosis in children and teenagers

June 21, 2022

What happens if hidradenitis suppurativa (HS) diagnosis is delayed in children?
Read more


Interview with 2018 Danby Grant Recipient Dr. Tina Porter

June 3, 2022

Dr. Alexander Charrow interviews Dr. Tina Porter, assistant professor at Harvard Medical School and 2018 Danby Grant Recipient, about her research on treating hidradenitis tunnels.
Read more


2022 Danby Awards

June 3, 2022

The HSF is pleased to announce the awarding of four Danby Research Grants in 2022, the most ever offered by the Foundation. These researchers are proposing exciting research initiatives in HS.
Read more


An Interview with 2019 Danby Research Grant Awardee John Frew, MBBS, PhD

June 2, 2022

Get to know the 2019 recipient and how his project aimed to identify potential clinical and therapeutic biomarkers of HS disease activity.
Read more


Negative Impacts of Hidradenitis Suppurativa in Pregnant Women

June 2, 2022

Women with HS were more likely to have health problems before pregnancy compared to women without HS.
Read more


HS surgeries associated with high satisfaction, brief recovery and tolerable pain

June 2, 2022

Considering surgery for treating hidradenitis suppurativa (HS) can feel intimidating, especially because it can be hard to know what to expect.
Read more


HSF Installs New Officers and Board Members at its March Board Meeting

April 6, 2022

During the recently held American Academy of Dermatology annual meeting in Boston, the HSF Board of Directors met and installed three new board members, as well as new officers. Dr. Joslyn Kirby will serve a two-year term as president.
Read more


A Deep Look at the Bacteria Living in Patients with HS

February 28, 2022

This research study explored the differences in the microbiome between unaffected individuals and those with HS by obtaining bacterial swabs from the skin, inside the nose, and stool from both groups.
Read more


Can Hidradenitis Suppurativa Affect Pregnancy?

August 30, 2021

Research on how HS affects pregnancy is limited, which is what led researchers at Penn State College of Medicine to perform a study that compared pregnancy outcomes in patients with and without HS.
Read more


Hidradenitis Suppurativa Foundation Danby Research Grants

May 25, 2021

For the past five years, the Hidradenitis Suppurativa Foundation (HSF) has proudly sponsored up to $10,000 for research projects that will have a sustained, powerful influence on our understanding of hidradenitis suppurativa (HS).
Read more


Clinical Epidemiology and Management of Hidradenitis Suppurativa

April 1, 2021

Understanding hidradenitis suppurativa clinical epidemiology and management facilitates early diagnosis and treatment, thereby reducing morbidity with the potential to favorably alter disease trajectory.
Read more


How should Pregnant and Nursing Mothers manage Hidradenitis Suppurativa?

February 28, 2021

With a growing need to properly manage HS in pregnant and nursing mothers, here we discuss the article “Management of Hidradenitis Suppurativa in Pregnancy” published in 2017 that provides the most up-to-date information.
Read more


How clear is the link between Hidradenitis Suppurativa and Inflammatory Bowel Disease?

February 19, 2021

Some research studies showed the HS and IBD are more likely to happen together, but two other studies did not show a link between them. The goal of this study was to combine all of the best studies and try to clear up whether there is a link between HS and IBD.
Read more


Comorbidity screening in hidradenitis suppurativa

January 22, 2021

Systematic reviews were performed to summarize evidence on the prevalence and incidence of 30 comorbidities in patients with HS relative to the general population.
Read more


COVID-19 Vaccines: Information for People with HS & their Caregivers

December 19, 2020

We know that you and your family probably have many questions about the COVID-19 vaccines that are being approved by the U.S. Food and Drug Administration (FDA). We are here to help and provide you with the most current information.
Read more


How are Emergency Departments treating pain in Hidradenitis Suppurativa?

November 18, 2020

For many patients with Hidradenitis Suppurativa (HS), pain is a problem that can lead to visits to the Emergency Department (ED).
Read more


Are people willing to use teledermatology for Hidradenitis Suppurativa care?

June 5, 2020

In new, yet unpublished data from a project by Joslyn Kirby, Ashley Eichelberger, Melissa Butt, Colleen Silva, and Aretha Mosley of Penn State Hershey School of Medicine, patients shared their thoughts and experience about long-distance dermatology visits.
Read more


The Hidden, Common Disease You've Never Heard Of

June 2, 2020

In today’s informed and connected world, it’s hard to believe there might be common diseases that you have never heard of.
Read more


6 Myths about Hidradenitis Suppurativa

June 1, 2020

We addressed 6 myths about Hidradenitis Suppurativa
Read more


Is COVID more risky for people treated for an immune disease?

May 22, 2020

In a study led by Dr. Rebecca Haberman of New York University, a group of doctors studied whether people being treated for immune diseases had more severe COVID.
Read more


What is the right dose of infliximab for Hidradenitis Suppurativa?

April 20, 2020

Infliximab is an intravenous (IV) medication that can help Hidradenitis Suppurativa (HS). The dose and timing of infliximab vary. The authors determined which dose was the best when starting treatment for HS.
Read more


Global Registry for Hidradenitis Suppurativa + COVID-19

April 17, 2020

International HS experts have recently established the Global HS COVID-19 Registry to better understand the risk of infection and clinical course of HS patients in the setting of COVID-19.
Read more


Anything new out there to help treat my HS?

April 11, 2020

In recent years, research has led to a deeper understanding of immune imbalances that may lead hidradenitis suppurativa (HS).
Read more


Frequently Asked Questions about Hidradenitis Suppurativa (HS) and COVID-19

April 6, 2020

What is COVID-19, and how is it different from the flu or other infections we have dealt with?
Read more


A new way to measure the extent of patients’ hidradenitis suppurativa

March 31, 2020

This study was done by researchers in the U.S.A. to find how well clinicians could measure HS using a different approach.
Read more


COVID-19 & Hidradenitis Suppurativa Podcast

March 24, 2020

HSF partnered with LearnSkin on a special podcast episode to bring expert insight into what COVID-19 means for dermatologists and their patients with Hidradenitis Suppurativa.
Read more


Plastic Surgical Management of Hidradenitis Suppurativa

March 10, 2020

Successful treatment of hidradenitis suppurativa requires a multidisciplinary team approach and multimodal therapy.
Read more


New drug shows promise for Hidradenitis Suppurativa treatment

February 27, 2020

An early study for bermekimab shows improvement in Hidradenitis Suppurativa (HS) activity and pain scores while demonstrating safety.
Read more


A study into the risk of serious infections in people with hidradenitis suppurativa

February 3, 2020

This study's aim was to determine if associations between HS and various serious infections exist, using the National Inpatient Sample, a USA database of inpatient hospitalizations, between the years 2002 and 2012. The study also looked into the cost of care and length of stay of HS patients with serious infections.
Read more


Pain perception and depression in patients with hidradenitis suppurativa

January 2, 2020

HS causes pain, but few studies have looked at this aspect. The authors aimed to study pain in patients with HS.
Read more


A review of use of the word ‘flare’ in hidradenitis suppurativa studies

January 2, 2020

HS lesions can come-and-go or last for months or years. HS can have times where it is worse than usual. These have been called ‘flares’. To measure flares in future studies, a definition for a flare is needed. This study was done to find out how flares were defined in past studies.
Read more


Incidence of Myocardial Infarction and Cerebrovascular Accident in Patients With Hidradenitis Suppurativa

November 13, 2019

New findings, recently published in JAMA Dermatology, appear to show that having HS confers a modest risk of having a heart attack or a stroke.
Read more


Most Hidradenitis Suppurativa patients improve with infliximab, if the dose is high enough

October 4, 2019

Some Hidradenitis Suppurativa patients improve when they receive infliximab, but we don’t know the proper dose of infliximab to give.  This research asked whether high-dose infliximab helps Hidradenitis Suppurativa patients.
Read more


Investigation of the skin microbiome

September 1, 2019

Researchers from Sweden, Ireland and the UK looked at the difference between the results of swabs and actual biopsies (tissue samples) of the skin.
Read more


Inter-rater reliability and agreement hidradenitis suppurativa instruments

September 1, 2019

This study aimed to find out how consistently 12 HS-experienced dermatologists would score 24 patients with HS, using nine different instruments.
Read more


Inter- and intrarater reliability of Hurley staging

August 1, 2019

This study, which was an international co-operation between departments in Germany, Denmark and Poland, was designed to check the agreement between different dermatologists, including those in training, on their rating of the stage of HS in 5 different patients on two separate occasions.
Read more


Association between HS and hospitalization for psychiatric disorders

August 1, 2019

The researchers of this study are based in U.S.A. and aimed to find out if hidradenitis is linked with higher likelihood and costs of mental health disorders.
Read more


Impact of HS on work loss, indirect costs and income

July 1, 2019

This study aimed to find out how the work life of people with HS was impacted compared to similar people without HS.
Read more


Pyrin mutations in complex hidradenitis suppurativa

June 3, 2019

This study, performed by researchers from Turkey and Germany, looked at the role of a gene called MEFV gene in HS, using a group of 119 people with the disease.
Read more


What’s the risk of lymphoma in people with HS?

May 1, 2019

This study was done to look at whether the inflammation from HS might increase the chance that someone’s immune system could go off the rails and cause lymphoma.
Read more


Cost-savings in hidradenitis suppurativa

April 26, 2019

This study, undertaken at the ATTIKON University Hospital of Athens, Greece, suggests adalimumab could be a cost-effective and efficient treatment for HS.
Read more


BAD guidelines for the management of HS (acne inversa) 2018

April 26, 2019

The British Association of Dermatologists commissioned a HS guideline development group composed of information specialists, a HS patient and carer, and UK clinicians including dermatologists, a dermatology nurse, plastic surgeon and general practitioner (GP). The group, based in the UK, were asked to produce treatment recommendations based on a systematic review of the evidence.
Read more


Does Hidradenitis Suppurativa cause skin cancer?

April 1, 2019

Longstanding Hidradenitis Suppurativa (HS) can be associated with other complications, such as intestinal problems and skin cancer.
Read more


Patients with self-reported HS in a cohort of Danish blood donors

April 1, 2019

The unique nature of HS makes it possible to diagnose the disease using questionnaires.
Read more


Illness perceptions and health outcomes in HS

February 4, 2019

In this study from a specialised HS clinic in a large UK hospital, dermatologists collaborated with psychologists to establish for the first time, the relationships between illness perceptions and health outcomes.
Read more


Imbalanced Th17/Treg axis in hidradenitis suppurativa

August 24, 2018

The aim of this study from the German Universities of Osnabrück and Munich was to clarify whether obesity and smoking promote the Th17/Treg imbalance.
Read more


Complement in hidradenitis suppurativa

August 24, 2018

This is a study on the pathogenesis (causes) of hidradenitis suppurativa (HS).
Read more


Hidradenitis suppurativa treated with secukinumab

July 19, 2018

Medications targeting small proteins called cytokines could provide a possible treatment approach for HS in the future.
Read more


Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis

April 18, 2018

Our study team based in the UK aimed to use UK electronic data recorded by General Practitioners (GPs) to identify known and previously undiagnosed cases of HS.
Read more


Prevalence of hidradenitis suppurativa among patients with Down syndrome: a population-based cross-sectional analysis

March 29, 2018

In this study, we evaluated the commonness of hidradenitis suppurativa within a large group of patients who had Down syndrome, and we used another groups of patients that did not have Down syndrome to compare findings.
Read more


Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the U.S.A.

March 29, 2018

Despite a common belief that tobacco smoking increases the risk of developing the disease, the evidence linking the two is controversial.
Read more


Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings

March 29, 2018

This study aimed to find out what clinical trials for HS should measure, such as symptoms (e.g. pain, itch), physical changes (e.g. skin redness or swelling), or impact on people's lives (e.g. quality of life).
Read more


Interleukin-36 in hidradenitis suppurativa

March 29, 2018

Scientists from Germany investigated whether a cytokine called interleukin-36 (IL-36) might be important in hidradenitis suppurativa (HS).
Read more


A phenotype combining hidradenitis suppurativa with Dowling–Degos disease caused by a founder mutation in PSENEN

February 18, 2018

In this present study, we showed a new genetic defect in PSENEN that can cause two diseases at once: Dowling-Degos disease and hidradenitis suppurativa.
Read more


Hidradenitis suppurativa and electrocardiographic changes: a cross-sectional population study

January 22, 2018

The aim of this study from Denmark was to investigate this possible cardiovascular burden associated with HS influence on the heart's electrical activity.
Read more


Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa

October 5, 2015

This study, from Germany, sought to identify the cellular sources of IL-17 in HS, and looked at a range of other factors that might contribute to the development of the disease, including the presence and source of other proteins that are involved in HS.
Read more


Diagnostic delay in hidradenitis suppurativa is a global problem

July 21, 2015

In this study, 517 patients with HS and 516 patients with another skin disease, psoriasis, from 24 countries were asked about the time it took to first see a doctor and then receive a diagnosis.
Read more


The Hidradenitis Suppurativa Priority Setting Partnership

June 5, 2014

According to the authors of this study, HS has been relatively neglected by society and medical research funding bodies, resulting in a lack of evidence to guide HS care. A Priority Setting Partnership (PSP) for HS was established following a model created by the James Lind Alliance which helps to bring patients, carers and clinicians together to identify and prioritise for research the treatment uncertainties which they agree are the most important.
Read more